Study title:
Thyroid. 2002 Feb;12(2):155-61.
Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the
follow-up of Hürthle cell thyroid cancer.
Plotkin M, Hautzel H, Krause BJ, Schmidt D, Larisch R, Mottaghy FM, Boemer AR,
Herzog H, Vosberg H, Müller-Gärtner HW.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|